Document ID: EPA-HQ-OPP-2006-0642-0020
Agency: epa
Document Type: Supporting & Related Material
Title: 
Posted Date: 2007-04-18T04:00Z

[Federal Register: September 28, 1994]

=======================================================================

-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

40 CFR Part 180

[OPP-300362; FRL-4912-5]

RIN 2070-AB78

 

Neomycin Phosphotransferase II; Tolerance Exemption

AGENCY: Environmental Protection Agency (EPA)

ACTION: Final rule.

-----------------------------------------------------------------------

SUMMARY: This document establishes an exemption from the requirement of 

a tolerance for residues of neomycin phosphotransferase II (NPTII) and 

the genetic material necessary for its production when used as a plant 

pesticide inert ingredient. Monsanto Co. petitioned EPA for this 

exemption.

EFFECTIVE DATE: This regulation becomes effective September 28, 1994.

ADDRESSES: Written objections and hearing requests, identified by the 

document control number, [OPP-300362], may be submitted to: Hearing 

Clerk (1900), Environmental Protection Agency, Rm. M3708, 401 M St., 

SW., Washington, DC 20460. A copy of any objections and hearing 

requests filed with the Hearing Clerk should be identified by the 

document control number and submitted to: Public Response and Program 

Resources Branch, Field Operations Division (7506C), Office of 

Pesticide Programs, Environmental Protection Agency, 401 M St., SW., 

Washington, DC 20460. In person, bring copy of objections and hearing 

requests to: Rm. 1132, CM #2, 1921 Jefferson Davis Hwy., Arlington, VA 

22202. Fees accompanying objections shall be labeled ``Tolerance 

Petition Fees'' and forwarded to: EPA Headquarters Accounting 

Operations Branch, OPP (tolerance fees), P.O. Box 36027M, Pittsburgh, 

PA 15251.

FOR FURTHER INFORMATION CONTACT: By mail: Phillip O. Hutton, Product 

Manager (PM 18), Registration Division (7505C), Office of Pesticide 

Programs, Environmental Protection Agency, 401 M St., SW., Washington, 

DC. Office location and telephone number: Rm. 213, CM #2, 1921 

Jefferson Davis Hwy., Arlington, VA 22202, (703)-305-7690.

SUPPLEMENTARY INFORMATION: In the Federal Register of December 8, 1993 

(58 FR 64582, 64583), EPA issued notices which announced that Monsanto 

Co., 700 Chesterfield Parkway North, St. Louis, MO 63193, had submitted 

a pesticide petition (PP 3F4273) to EPA proposing to amend 40 CFR part 

180 to establish an exemption from the requirement of a tolerance for 

neomycin phosphotransferase II (NPTII), and the genetic material 

necessary to produce NPTII when produced in plants as a plant pesticide 

inert ingredient. The Agency did not receive any comments on the 

notices. Selectable markers such as NPTII are considered inert 

ingredients by the Agency when they are introduced into a plant in 

order to ensure or confirm the presence of a plant pesticide. The 

genetic material necessary to produce NPTII (the NPTII gene) is also 

considered part of the inert ingredient; therefore, the NPTII gene is 

also addressed in this final rule.

    Neomycin phosphotransferase II (NPTII) is uniquely different from 

other types of inert ingredients because it is a selectable marker used 

to identify plant cells early in the product development that had been 

successfully transformed to express the active ingredient.

    The data submitted in the petition and other relevant material have 

been evaluated and deemed sufficient to support the tolerance. The 

rationale for this decision is described below.

Assessment of Data

    The Agency has evaluated the toxicology data, information on 

product identity, equivalence of microbially and plant produced NPTII, 

and other information provided by the petitioner. The information 

showed that the plant and microbially produced protein are similar with 

respect to the protein characteristics of amino acid sequence, enzyme 

activity, electrophoretic mobility, lack of glycosylation, and specific 

antibody recognition. These findings justified the use of microbial 

protein in the toxicity studies. The registrant provided the following 

studies: Acute Oral Toxicity of NPTII in Mice and an In Vitro Digestion 

of the NPTII Protein. A single oral exposure dose of 5 g/kg NPTII 

protein produced no adverse effects in mice. The In Vitro Digestion 

study showed that the protein was rapidly degraded in simulated gastric 

or intestinal digestive fluids to fragments that were no longer 

recognized by specific antibodies to NPTII. These results suggest the 

NPTII protein will not survive passage through the gastrointestinal 

tract. Therefore, the Agency concluded that the information provided 

was sufficient to assess the acute toxicity of NPTII when used as a 

marker gene in transgenic plants expressing plant pesticides and to 

justify an exemption from the requirement for a food tolerance for 

residues of the inert. The Agency recognizes that alternative 

information could be used to indicate the lack of mammalian toxicity 

and to justify a tolerance exemption.

    Since no toxicity was indicated, residue chemistry data were not 

required. Residue data are necessary only if the submitted toxicity 

studies indicate that additional toxicology data were needed. These 

additional data were not needed. Therefore, no residue data are 

required in order to grant an exemption from the requirement of a 

tolerance for the plant pesticide inert ingredient neomycin 

phosphotransferase II when used as a plant pesticide inert ingredient, 

as expressed in plant cells.

    The exemption from a tolerance for the genetic material which 

encodes for production of NPTII is based on the fact that the nucleic 

acids which form the genetic material are found in all foods and have 

not, by themselves, been associated with toxic or pathogenic effects in 

animals and humans. None of the constituents of nucleic acids are known 

to be acute toxicants by themselves but, like proteins and other normal 

constituents in food, may cause indirect, adverse metabolic effects if 

consumed exclusively at high doses over a long period of time in the 

absence of a normal diet. The NPTII gene will not occur at these high 

amounts in plants. Thus, EPA does not believe there is a potential for 

adverse health effects related to the consumption of plants containing 

the NPTII gene.

    Acceptable daily intake (ADI) and maximum permissible intake (MPI) 

considerations are not relevant to this petition because the data/

information submitted demonstrate that this plant-pesticide inert 

ingredient (NPTII) and the NPTII gene are not toxic to mammalian 

species. No enforcement actions are expected based upon the level of 

residue for NPTII and the genetic material necessary for its 

production. Therefore, the requirement for an analytical method for 

enforcement purposes is not applicable to this exemption.

    Based on the above information and review of its use, EPA has found 

that when used in accordance with good agricultural practice, this 

ingredient is useful for the purpose for which the tolerance exemption 

is sought. Based on the information considered, EPA concludes that a 

tolerance is not necessary to protect the public health. Therefore, the 

exemption from the requirement of a tolerance is established as set 

forth below.

    Any person adversely affected by this regulation may, within 30 

days after publication of this document in the Federal Register, file 

written objections and/or a request for a hearing with the Hearing 

Clerk, at the address given above (40 CFR 178.20). A copy of the 

objections and hearing requests filed with the Hearing Clerk should be 

submitted to the OPP docket for this rulemaking. The objections 

submitted must specify the provisions of the regulation deemed 

objectionable and the grounds for the objections (40 CFR 178.25). Each 

objection must be accompanied by the fee prescribed by 40 CFR 

180.33(i). If a hearing is requested, the objections must include a 

statement of the factual issue(s) on which a hearing is requested, the 

requestor's contentions on each such issue, and a summary of any 

evidence relied upon by the objector (40 CFR 178.27). A request for a 

hearing will be granted if the Administrator determines that the 

material submitted shows the following: There is a genuine and 

substantial issue of fact; there is a reasonable possibility that 

available evidence identified by the requestor would, if established, 

resolve one or more of such issues in favor of the requestor, taking 

into account uncontested claims or facts to the contrary; and 

resolution of the factual issue(s) in the manner sought by the 

requestor would be adequate to justify the action requested (40 CFR 

178.32).

    The Office of Management and Budget has exempted this rule from the 

requirements of section 2 of Executive Order 12866.

    Pursuant to the requirements of the Regulatory Flexibility Act 

(Pub. L. 96-354, 94 Stat. 1164, 5 U.S.C. 601-612), the Administrator 

has determined that regulations establishing new tolerances or raising 

tolerance levels or establishing exemptions from tolerance requirements 

do not have a significant economic effect on a substantial number of 

small entities. A certification statement to this effect was published 

in the Federal Register of May 4, 1981 (49 FR 24950).

List of Subjects in 40 CFR Part 180

    Environmental protection, Administrative practice and procedure, 

Agricultural commodities, Pesticides and pests, Reporting and 

recordkeeping requirements.

Dated: September 19, 1994.

Stephen L. Johnson,

Director, Registration Division, Office of Pesticide Programs.

    Therefore, 40 CFR part 180 is amended as follows:

PART 180--[AMENDED]

    1. The authority citation for part 180 continues to read as 

follows:

    Authority: 21 U.S.C. 346a and 371.

    2. In subpart D, by adding new Sec. 180.1134, to read as follows:

Sec. 180.1134   Neomycin phosphotransferase II and genetic material 

necessary for its production; exemption from the requirement of a 

tolerance.

    The neomycin phosphotransferase II (NPTII) and the genetic material 

necessary for the production of this protein are exempted from the 

requirement of a tolerance in or on all raw agricultural commodities 

when used as a plant-pesticide inert ingredient.

[FR Doc. 94-23762 Filed 9-27-94; 8:45 am]

BILLING CODE 6560-50-F